Covid - I'm banned, your the witness, Moderna, GLM, Jackpot
Welcome and thank you to all the new, smart, savvy and contrarian investors to my substack. If you like outside the box thinking, a humble analyst that has spent his career studying market and economic cycles, picked numerous tops and bottoms, someone not afraid of controversial topics and can be a bull and a bear, your at the right place. Please share and subscribe.
The S&P 500 ended up about +2% in September, making it one of the better Septembers. However, we now enter scary October. October is not only Halloween but is know for abrupt corrections and crashes. The October effect, it's one of the most feared months in the financial calendar. The Bank Panic of 1907, the Stock Market Crash of 1929, Black Monday 1987 and the 2008 finacial crisis all happened during the month of October.
And for this October we have the Ukraine war, an escalating Middle East war and the election early November. Fasten your seat belts, but the good news is the Fed could cut another 50 points in November.
Covid - I've been banned, you can witness the article
I use to write many articles on Seeking Alpha (SA). I had thousands of followers and many of my articles saw 10,000 to 15,000 views. I made many excellent calls like some on Tesla. I called the bottom bang on with my 'A Perfect Storm Hit Tesla' report in January 2023.
https://seekingalpha.com/article/4568733-a-perfect-storm-hit-tesla-in-2022
My report to short Moderna in August 2023 was also bang on. However, that was my last report. My report was correct, but I guess it was not politically correct. I had to do 3 or 4 edits of the report before it was accepted and was then told that I was not allowed to submit anymore articles. I tried one a couple weeks ago on B2Gold and was told again that I am banned. So I guess that is that.
I wanted to highlight my Moderna report because it will probably get deleted. And it does have a lot of good Covid related info. You read and decide how politically incorrect it was. The Title is -
Moderna Falling As Vaccine Hesitancy Rises
https://seekingalpha.com/article/4626692-moderna-falling-as-vaccine-hesitancy-rises
In my article, I went into details of Moderna's poor financial situation and outlook.
I never made a negative comment about the shots, but provided numerous articles that I said would cause vaccine hesitancy to rise:
I provided evidence the UK and other European countries were no longer recommending Covid shots for those under 50;
I highlighted a study by the South Korean Government;
I highlighted another study that the shots were causing immune problems. This was by doctors/scientists at the University of Southern Florida, a University in Saudi Arabia, Cross Cancer Institute in Edmonton Canada and a Hospital and University in Mexico;
I showed the US Fed job numbers where disability claims skyrocketed after the shots;
I provided the Pfizer documents the European Medicines Agency released that showed over 1.5 million adverse events, most never admitted by Pfizer;
A Federal Judge ordered the FDA to release the Moderna documents faster and I revealed the first 15,000 pages that raised concerns;
Documents from Israel Ministry of Health revealed ZERO Covid deaths in those under 50;
I quoted Meta CEO Mark Zuckerberg who admitted there was censorship around Covid;
I provided a survey by the Public Health Agency of Canada that only 22% would trust federal agencies since the pandemic;
A U.S. study by Pew Research that showed vaccine hesitancy was rising.
Plain and simple, I provided information from very credible and reliable sources that could not be disputed. And made it obvious that vaccine hesitancy was very high and rising.
I concluded that Moderna stock just fell through $115 and I saw the next target as $70. Meanwhile 24 analysts were mostly cheerleaders with the average recommending an over weight position and an average $182.72 target. It did not take a rocket scientist to see I would be right and by November the stock went just below $70 before recovering in 2024. I suggested the November $110 Put options that did extremely well, almost 200% gain.
Moderna Today (MRNA) $66.56
Moderna faces significant headwinds as demand for COVID-19 vaccines wanes and competition intensifies. The company’s reliance on a single product line raises concerns about revenue stability. Additionally, its R&D pipeline, while promising, has yet to deliver commercially viable alternatives. Investors should be wary of high valuations that may not be justified, especially in a rapidly changing market. Regulatory hurdles and potential litigation could further impact profitability, making MRNA a risky bet for the foreseeable future.
Moderna's price to sales is about twice as high as Pfizer and BioNtech. Insiders have been dumping shares all year, selling $86 million worth in last 12 months. Short Interest is starting to rise, from around 21/22 million to 25.6 million shares end of August and 27.6 million at September 15.
I was considering shorting Moderna this summer but was waiting closer to September. I waited too long but there could be another opportunity. Moderna is losing a lot of $$ and does not deserve a higher price to sales ratio than Pfizer and BioNtech. I also consider Messenger RNA (Mrna) a failed technology. There is no reason to believe their Mrna vaccines in their pipeline will be any better and safer than their Covid-19 one. The company could be hit with lawsuits at anytime and I don't believe their reputation is going to help future sales. The company continues to miss their rosy forecasts.
All that said, the stock has seen a large decline and I think we could see at least a relief rally. Technically the stock is broken because it made lows below those of last November. I am watching the stock and chart, so stay tuned for a possible Put options suggestion.
Golden Lake - - CSE:GLM, OTCQB:GOLXF - - - - Recent Price – C$0.06
Entry Price - $0.20 - - - - Opinion – strong buy
GLM announced that it has commenced drilling on its flagship Jewel Ridge property, Nevada.
The Property is well-located proximal to infrastructure and is immediately adjacent to successful, high-profile exploration programs currently being undertaken by North Peak Resources Ltd. & i-80 Gold Corp. (IAU.TO), on their neighboring Prospect Mountain and Ruby Hill properties, respectively.
HD Drilling Services, based out of Winnemucca, Nevada, has been retained by the Company to complete the 1,700-meter drill program. The program will consist of 4 to 5 high-priority drill targets and is anticipated to take 2 to 3 weeks to complete.
These high-priority drill targets include Induced Polarization (IP) anomalies generated from 2024 surveys situated within favorable geological & structural settings. Such settings host both Carlin-type disseminated gold deposits and carbonate replacement deposits, which are prominent in the immediate area of the South Eureka Gold Belt, where the Jewel Ridge property is located. Other targets include historic mines yielding high precious and base-metal assays, largely exploited at shallow depth that have seen no historic drilling. Full details of the drill targets can be found at www.goldenlakex.com.
Given the high profile of this location and how cheap Golden Lake is to it's peers, I believe the stock is going to move higher ahead of drill results.
Jackpot Digital - - - TSX:JJ, OTC:JPOTF - - - - Recent Price - $0.075
Entry Price - $0.06 - - - Opinion – buy, strong buy on 9 cent breakout
I call Jackpot the best Casino AI stock and for good reason. However nobody knows yet.
Last week Jackpot received approval from the Saskatchewan Liquor and Gaming Authority (SLGA) to act as a registered supplier of gaming supplies and services to regulated casinos in the Canadian province of Saskatchewan.
The approval follows the company's news release dated Feb. 6, 2024, announcing the signing of a licensing agreement with the Saskatchewan Indian Gaming Authority (SIGA) to install the company's Jackpot Blitz dealerless poker ETGs (electronic table games) into SIGA casinos.
SIGA operates seven casinos and Playnow.com in Saskatchewan. At the outset, SIGA proposes to install Jackpot Blitz machines at its Dakota Dunes and Gold Horse Casino properties, located in Saskatoon and Lloydminster, respectively.
Jackpot chief executive officer Jake Kalpakian states: "We are excited to receive approval as a gaming equipment supplier in Saskatchewan. This represents the first major jurisdictional, non-tribal licence received by Jackpot during our continuing expansion into the land-based casino market. We have many more licence applications under way in the U.S. and other Canadian provinces, which will dramatically impact our ability to accelerate the rollout of Jackpot Blitz across North America."
There was also big news on Sept 5th, Jackpot successfully completed the installation of four Jackpot Blitz electronic table games (ETGs) at Gold Country Casino Resort, located in Oroville, Calif. This is the company's largest installation to date of its next-generation (land-based) Jackpot Blitz ETGs. This created Gold County's fully automated poker room, the Jackpot Blitz poker room beside their sports bar.
I can't believe the stock is this cheap. If it does not move higher sooner, eventually swelling revenues will drive the stock or it might get discovered by people using their tables in casinos that connect the dots. I am going to suggest to the CEO that they put the OTC stock symbol with their logo on the tables.
And for those that don't know the company and it's amazing product, just check this 2 minute video.
(127) Pro Football Hall of Fame Coach Jimmy Johnson Introduces Jackpot Blitz - YouTube
There is also a more recent video in a California casino
(127) Jackpot Blitz as seen on Fox TV - YouTube
The stock has been edging higher but it needs to break above resistance at 9 cents and is why I have a strong buy on that break out.
Paid Advertisers at playstocks
All forecasts and recommendations are based on opinion. Markets change direction with consensus beliefs, which may change at any time and without notice. The author/publisher of this publication has taken every precaution to provide the most accurate information possible. The information & data were obtained from sources believed to be reliable, but because the information & data source are beyond the author's control, no representation or guarantee is made that it is complete or accurate. The reader accepts information on the condition that errors or omissions shall not be made the basis for any claim, demand or cause for action. Because of the ever-changing nature of information & statistics the author/publisher strongly encourages the reader to communicate directly with the company and/or with their personal investment adviser to obtain up to date information. Past results are not necessarily indicative of future results. Any statements non-factual in nature constitute only current opinions, which are subject to change. The author/publisher may or may not have a position in the securities and/or options relating thereto, & may make purchases and/or sales of these securities relating thereto from time to time in the open market or otherwise. Neither the information, nor opinions expressed, shall be construed as a solicitation to buy or sell any stock, futures or options contract mentioned herein. The author/publisher of this letter is not a qualified financial adviser & is not acting as such in this publication.